This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Daniél Vega Møller: Innovator in Alzheimer's Disease Treatment
Introduction
Daniél Vega Møller is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. His innovative approach has garnered attention in the scientific community.
Latest Patents
Daniél holds a patent titled "Methods for Treating Alzheimer's Disease Using Semaglutide." This patent represents a breakthrough in the therapeutic strategies aimed at combating this debilitating condition. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Daniél is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk focuses on developing innovative treatments that improve patient outcomes. His expertise and dedication have positioned him as a key player in the field of Alzheimer's research.
Collaborations
Daniél collaborates with talented colleagues, including Charlotte Christine Thim Hansen and Lotte Bjerre Knudsen. These partnerships enhance the research efforts and contribute to the development of effective treatments.
Conclusion
Daniél Vega Møller is a dedicated inventor whose work in Alzheimer's disease treatment is paving the way for future advancements in medicine. His contributions are vital to improving the lives of those affected by this condition.